Suppr超能文献

成人生命历程中的体重指数轨迹与胰腺癌风险。

Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk.

机构信息

Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Rutgers New Jersey Medical School, Newark, NJ, USA.

出版信息

JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac066.

Abstract

BACKGROUND

Body mass index (BMI) during adulthood has been associated with pancreatic ductal adenocarcinoma (PDAC), however, patterns of body size across the adult life course have not been studied extensively. We comprehensively evaluated the association between adiposity across adulthood and PDAC.

METHODS

We conducted a prospective analysis of 269 480 (162 735 males, 106 745 females) National Institutes of Health-AARP Diet and Health Study participants, aged 50-71 years (1995-1996) who self-reported height and weight history. Participants were followed through December 31, 2011. We examined associations between BMI (kg/m2) at ages 18, 35, 50, and 50-71 (baseline) years, their trajectories determined from latent-class trajectory modeling, and incident PDAC. Cox proportional hazard models were used to calculate multivariable adjusted hazards ratios (HRs) and 95% confidence intervals (CIs).

RESULTS

During up to 15.2 years of follow-up, 3092 (2020 males, 1072 females) patients with incident PDAC were identified. BMI at all 4 ages were statistically significantly associated with increased PDAC (per 5-unit increase, HR = 1.09-1.13) with higher magnitude associations in males than females at ages 35 years and older (Pinteraction < .05). Four BMI trajectories were created. Compared with normal-weight maintainers, normal-to-overweight, normal-to-obese class I, and overweight-to-obese class III trajectories had hazard ratios of 1.15 (95% CI = 1.06 to 1.25), 1.39 (95% CI = 1.25 to 1.54), and 1.48 (95% CI = 1.18 to 1.87), respectively (Pinteraction by sex = .07).

CONCLUSIONS

High BMI and BMI trajectories that result in overweight or obesity during adulthood were positively associated with PDAC, with stronger associations among those with early onset adiposity and those with male sex. Avoidance of excess body weight throughout the adult life course may prevent PDAC.

摘要

背景

成年人的体重指数(BMI)与胰腺导管腺癌(PDAC)有关,然而,成年期的体型模式尚未得到广泛研究。我们全面评估了成年期肥胖与 PDAC 之间的关系。

方法

我们对 269480 名(男性 162735 名,女性 106745 名)美国国立卫生研究院-美国退休人员协会饮食与健康研究参与者进行了前瞻性分析,这些参与者年龄在 50-71 岁(1995-1996 年),报告了身高和体重史。参与者随访至 2011 年 12 月 31 日。我们研究了 BMI(kg/m2)在 18、35、50 岁及 50-71 岁(基线)时的相关性,以及通过潜在类别轨迹建模确定的 BMI 轨迹与 PDAC 发病之间的相关性。Cox 比例风险模型用于计算多变量调整后的风险比(HR)和 95%置信区间(CI)。

结果

在长达 15.2 年的随访期间,共发现 3092 名(男性 2020 名,女性 1072 名)PDAC 患者。所有 4 个年龄的 BMI 均与 PDAC 风险增加显著相关(每增加 5 个单位,HR=1.09-1.13),且男性在 35 岁及以上年龄时的相关性高于女性(P 交互作用<0.05)。创建了 4 种 BMI 轨迹。与体重正常的维持者相比,正常体重至超重、正常体重至肥胖 I 类和超重至肥胖 III 类的 HR 分别为 1.15(95%CI=1.06-1.25)、1.39(95%CI=1.25-1.54)和 1.48(95%CI=1.18-1.87)(性别交互作用 P=0.07)。

结论

成年后 BMI 升高和导致超重或肥胖的 BMI 轨迹与 PDAC 呈正相关,在发病较早的肥胖者和男性中相关性更强。在整个成年期避免体重增加可能有助于预防 PDAC。

相似文献

1
Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk.
JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac066.
2
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.
Am J Clin Nutr. 2013 Oct;98(4):1057-65. doi: 10.3945/ajcn.113.058123. Epub 2013 Aug 28.
3
Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study.
Scand J Surg. 2023 Mar;112(1):11-21. doi: 10.1177/14574969221127530. Epub 2022 Sep 29.
5
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
JAMA. 2009 Jun 24;301(24):2553-62. doi: 10.1001/jama.2009.886.
7
Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.
Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1651-1659. doi: 10.1158/1055-9965.EPI-23-0668.
8
Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.
Int J Cancer. 2017 Jul 15;141(2):271-278. doi: 10.1002/ijc.30737. Epub 2017 Apr 26.
9
Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer.
Breast Cancer Res. 2023 Oct 28;25(1):130. doi: 10.1186/s13058-023-01729-x.

引用本文的文献

1
Clinical significance of risk factor analysis in pancreatic cancer by using supervised model of machine learning.
Front Med (Lausanne). 2025 May 26;12:1551926. doi: 10.3389/fmed.2025.1551926. eCollection 2025.
4
Body mass index across adulthood, weight gain and cancer risk: a population-based cohort study.
BMC Cancer. 2025 Mar 17;25(1):488. doi: 10.1186/s12885-025-13855-0.
6
Do Polygenic Risk Scores Add to Clinical Data in Predicting Pancreatic Cancer? A Scoping Review.
Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1490-1497. doi: 10.1158/1055-9965.EPI-23-0468.

本文引用的文献

2
American Cancer Society's report on the status of cancer disparities in the United States, 2021.
CA Cancer J Clin. 2022 Mar;72(2):112-143. doi: 10.3322/caac.21703. Epub 2021 Dec 8.
3
Estimated Projection of US Cancer Incidence and Death to 2040.
JAMA Netw Open. 2021 Apr 1;4(4):e214708. doi: 10.1001/jamanetworkopen.2021.4708.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis.
JNCI Cancer Spectr. 2020 May 9;4(4):pkaa033. doi: 10.1093/jncics/pkaa033. eCollection 2020 Aug.
6
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.
Gastroenterology. 2021 Feb;160(3):744-754. doi: 10.1053/j.gastro.2020.10.007. Epub 2020 Oct 13.
8
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy.
World J Gastrointest Oncol. 2020 Feb 15;12(2):173-181. doi: 10.4251/wjgo.v12.i2.173.
9
Why Do Men Accumulate Abdominal Visceral Fat?
Front Physiol. 2019 Dec 5;10:1486. doi: 10.3389/fphys.2019.01486. eCollection 2019.
10
Pancreatic cancer: a growing burden.
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):895-896. doi: 10.1016/S2468-1253(19)30323-1. Epub 2019 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验